Antinociceptive and side-effects of hydromorphone after subcutaneous administration in cats

Journal of Feline Medicine and Surgery

Volumn 11, Issue 2, 2009, Pages 76-81

  Robertson, Sheilah A ^a   Wegner, Kirsten ^b   Lascelles, Benedict Duncan X ^c  

^a University of Florida College of Veterinary Medicine   (United States)

^b College of Veterinary Medicine ^*  (United States)

^c Center for Comparative Medicine and Translational Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROMORPHONE; NARCOTIC ANALGESIC AGENT;

ANIMAL; ANIMAL DISEASE; ARTICLE; CAT; CAT DISEASE; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; FEMALE; HYPERSALIVATION; MALE; METABOLISM; SKIN TEMPERATURE; SUBCUTANEOUS DRUG ADMINISTRATION; TIME; VOMITING;

ANALGESICS, OPIOID; ANIMALS; CAT DISEASES; CATS; FEMALE; HYDROMORPHONE; INJECTIONS, SUBCUTANEOUS; MALE; SIALORRHEA; SKIN TEMPERATURE; TIME FACTORS; VOMITING;

EID: 58349103309     PISSN: 1098612X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jfms.2008.05.003     Document Type: Article

References (34)

1. Pettifer G., and Dyson D. Hydromorphone: a cost-effective alternative to the use of oxymorphone. Can Vet J 41 (2000) 135-137
2. Niedfeldt R.L., and Robertson S.A. Postanesthetic hyperthermia in cats: a retrospective comparison between hydromorphone and buprenorphine. Vet Anaesth Analg 33 (2006) 381-389
3. Posner L.P., Gleed R.D., Erb H.N., and Ludders J.W. Post-anesthetic hyperthermia in cats. Vet Anaesth Analg 34 (2007) 40-47
4. Lascelles B.D., and Robertson S.A. Antinociceptive effects of hydromorphone, butorphanol, or the combination in cats. J Vet Int Med 18 (2004) 190-195
5. Wegner K., and Robertson S.A. Dose-related thermal antinociceptive effects of intravenous hydromorphone in cats. Vet Anaesth Analg 34 (2007) 132-138
6. Wegner K., Robertson S.A., Kollias-Baker C., Sams R.A., and Muir III W.W. Pharmacokinetic and pharmacodynamic evaluation of intravenous hydromorphone in cats. J Vet Pharmacol Ther 27 (2004) 329-336
7. Lamont L.A. Feline perioperative pain management. Vet Clin North Am Small Anim Pract 32 (2002) 747-763
8. Lukasik V. Premedication and sedation. In: Seymour C., and Gleed R.D. (Eds). Manual of Small Anim Anaesth and Analgesia (1999), British Small Animal Veterinary Association, Cheltenham 71-85
9. Taylor P.M., Robertson S.A., Dixon M.J., Ruprah M., Sear J.W., Lascelles B.D., Waters C., and Bloomfield M. Morphine, pethidine and buprenorphine disposition in the cat. J Vet Pharmacol Ther 24 (2001) 391-398
10. Robertson S.A., Taylor P.M., Lascelles B.D., and Dixon M.J. Changes in thermal threshold response in eight cats after administration of buprenorphine, butorphanol and morphine. Vet Rec 153 (2003) 462-465
11. Steagall P.V., Carnicelli P., Taylor P.M., Luna S.P., Dixon M., and Ferreira T.H. Effects of subcutaneous methadone, morphine, buprenorphine or saline on thermal and pressure thresholds in cats. J Vet Pharmacol Ther 29 (2006) 531-537
12. Dixon M.J., Robertson S.A., and Taylor P.M. A thermal threshold testing device for evaluation of analgesics in cats. Res Vet Sci 72 (2002) 205-210
13. Scholz J., Steinfath M., and Tonner P.H. Antiemetics. In: Evers A.S., and Maze M. (Eds). Anesthetic Pharmacology: Physiologic Principles and Clinical Practice: a Companion to Miller's Anesthesia (2004), Churchill Livingston, Philadelphia 777-791
14. Coda B., Tanaka A., Jacobson R.C., Donaldson G., and Chapman C.R. Hydromorphone analgesia after intravenous bolus administration. Pain 71 (1997) 41-48
15. Moulin D.E., Kreeft J.H., Murray-Parsons N., and Bouquillon A.I. Comparison of continuous subcutaneous and intravenous hydromorphone infusions for management of cancer pain. Lancet 337 (1991) 465-468
16. Ranheim B., Hoiset J., Framstad T., Horsberg T.E., Skaare J.U., and Soli N.E. Pharmacokinetics of pethidine in pigs following intravenous, intramuscular and subcutaneous administration. J Vet Pharmacol Ther 21 (1998) 491-493
17. Lascelles B.D., and Robertson S.A. Use of thermal threshold response to evaluate the antinociceptive effects of butorphanol in cats. Am J Vet Res 65 (2004) 1085-1089
18. Johnson J.A., Robertson S.A., and Pypendop B.H. Antinociceptive effects of intramuscular butorphanol, buprenorphine or their combination in cats. Am J Vet Res 68 (2007) 699-703
19. Bailey P.L., Egan T.D., and Stanley T.H. Intravenous opioid anesthetics. In: Miller R.D. (Ed). Anesthesia. 5th edn (2000), Churchill Livingstone, New York 273-376
20. Blancquaert J.P., Lefebvre R.A., and Willems J.L. Emetic and antiemetic effects of opioids in the dog. Eur J Pharmacol 128 (1986) 143-150
21. Stein C., and Rosow C.E. Analgesics: receptor ligands and opiate narcotics. In: Evers A.S., and Maze M. (Eds). Anesthetic Pharmacology: Physiologic Principles and Clinical Practice: a Companion to Miller's Anesthesia (2004), Churchill Livingstone, Philadelphia 457-471
22. Kovac A.L. Prophylaxis of postoperative nausea and vomiting: controversies in the use of serotonin 5-hydroxytryptamine subtype 3 receptor antagonists. J Clin Anest 18 (2006) 304-318
23. Valverde A., Cantwell S., Hernandez J., and Brotherson C. Effects of acepromazine on the incidence of vomiting associated with opioid administration in dogs. Vet Anaesth Analg 31 (2004) 40-45
24. Smith L.J., Yu J.K., Bjorling D.E., and Waller K. Effects of hydromorphone or oxymorphone, with or without acepromazine, on preanesthetic sedation, physiologic values, and histamine release in dogs. J Am Vet Med Assoc 218 (2001) 1101-1105
25. Thurmon J.C., Tranquilli W.J., and Benson G.J. Preanesthetics and anesthetic adjuncts. In: Thurmon J.C., Tranquilli W.J., and Benson G.J. (Eds). Lumb and Jones' Veterinary Anesthesia. 3rd edn (1996), Williams and Wilkins, Baltimore 183-209
26. Robertson S.A., Taylor P.M., and Sear J.W. Systemic uptake of buprenorphine by cats after oral mucosal administration. Vet Rec 152 (2003) 675-678
27. Robertson S.A., Lascelles B.D., Taylor P.M., and Sear J.W. PK-PD modeling of buprenorphine in cats: intravenous and oral transmucosal administration. J Vet Pharmacol Ther 28 (2005) 453-460
28. Robertson S.A., Taylor P.M., Sear J.W., and Keuhnel G. Relationship between plasma concentrations and analgesia after intravenous fentanyl and disposition after other routes of administration in cats. J Vet Pharmacol Ther 28 (2005) 1-7
29. Roy S.D., and Flynn G.L. Solubility and related physicochemical properties of narcotic analgesics. Pharm Res 5 (1988) 580-586
30. Ohtani M., Kotaki H., Sawada Y., and Iga T. Comparative analysis of buprenorphine- and norbuprenorphine-induced analgesic effects based on pharmacokinetic-pharmacodynamic modeling. J Pharmacol Exp Therap 272 (1995) 505-510
31. McEllistrem R.F., Bennington R.G., and Roth S.H. In vitro determination of human dura mater permeability to opioids and local anaesthetics. Can J Anaesth 40 (1993) 165-169
32. Wright A.W., Mather L.E., and Smith M.T. Hydromorphone-3-glucuronide: a more potent neuro-excitant than its structural analogue, morphine-3-glucuronide. Life Sci 69 (2001) 409-420
33. Court M.H., and Greenblatt D.J. Biochemical basis for deficient paracetamol glucuronidation in cats: an interspecies comparison of enzyme constraint in liver microsomes. J Pharm Pharmacol 49 (1997) 446-449
34. Court M.H., and Greenblatt D.J. Molecular basis for deficient acetaminophen glucuronidation in cats. An interspecies comparison of enzyme kinetics in liver microsomes. Biochem Pharmacol 53 (1997) 1041-1047